sponsored byAAAS Golden Fund

EurekAlert from AAAS
Home About us
Advanced Search
4-Dec-2012 00:24
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Portal: Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 451-475 out of 496.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 > >>

Public Release: 11-Jan-2012
International Journal of Food Safety, Nutrition and Public Health
Increase dietary fiber, decrease disease
We should all be eating more dietary fiber to improve our health -- that's the message from a health review by scientists in India. Writing in the International Journal of Food Safety, Nutrition and Public Health, the team offers fruit, vegetables, whole-grain foods, such as muesli and porridge, beans and pulses, as readily available foods rich in dietary fiber.

Contact: Vikas Rana
vikasranaji@gmail.com
Inderscience Publishers

Public Release: 10-Jan-2012
PLOS Pathogens
Researchers discover novel anti-viral immune pathway in the mosquito
Virginia Tech researchers have identified a novel anti-viral pathway in the immune system of culicine mosquitoes, the insect family to which mosquitoes that spread yellow fever, West Nile fever, dengue fever, and chikungunya fever belong.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Lindsay Key
ltkey@vt.edu
540-231-6594
Virginia Tech

Public Release: 10-Jan-2012
Aeras and CNBG sign agreement on tuberculosis vaccine R&D
Aeras and the China National Biotec Group announce that they have reached final agreement to jointly develop new tuberculosis vaccines. The agreement between the leading non-profit developer of TB vaccine candidates and the largest biotechnology corporation in China signals a commitment by both to engage and strengthen the role of China in the fight against one of the world's deadliest infectious disease killers.

Contact: Jamie Rosen
jrosen@aeras.org
301-547-2853
Aeras

Public Release: 10-Jan-2012
European Heart Journal
Global study sheds light on role of exercise, cars and televisions on the risk of heart attacks
A worldwide study, published in the European Heart Journal, has shown that physical activity during work and leisure time significantly lowers the risk of heart attacks in both developed and developing countries. Ownership of a car and a television was linked to an increased risk of heart attacks, particularly in low- and middle-income countries.

Contact: Emma Mason
wordmason@mac.com
European Society of Cardiology

Public Release: 9-Jan-2012
Science
Study reveals enzyme function, could help find muscular dystrophy therapies
Researchers at the University of Iowa have worked out the exact function of an enzyme that is critical for normal muscle structure and is involved in several muscular dystrophies. The findings, which were published Jan. 6 in the journal Science, could be used to develop rapid, large-scale testing of potential muscular dystrophy therapies.
National Institutes of Health

Contact: Jennifer Brown
jennifer-l-brown@uiowa.edu
319-356-7124
University of Iowa Health Care

Public Release: 9-Jan-2012
American Journal of Tropical Medicine and Hygiene
New study: Cholera in Haiti tracked more rapidly by social media than traditional methods
Internet-based news and Twitter feeds were faster than traditional sources at detecting the onset and progression of the cholera epidemic in post-earthquake Haiti that has already killed more than 6,500 people and sickened almost half a million, according to a new study published in the January issue of the American Journal of Tropical Medicine and Hygiene.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Public Release: 6-Jan-2012
Journal of Biological Chemistry
Scientists characterize protein essential to survival of malaria parasite
A biology lab at Washington University in St. Louis has successfully cracked the structure of an enzyme made by Plasmodium falciparum, the parasitical protozoan that causes the most lethal form of malaria. Plasmodium cannot live without the enzyme, which is uses to make cell membrane. Because people don't make this enzyme, it is an ideal target for an anti-malarial drug. Such a drug might kill Plasmodium but have minimal side effects for people.

Contact: Diana Lutz
dlutz@wustl.edu
314-935-5272
Washington University in St. Louis

Public Release: 5-Jan-2012
PLOS Neglected Tropical Diseases
Crucial gene activator in slow-killing parasite identified
Case Western Reserve University researchers have identified a gene activator crucial to development of flatworms that cause schistosomiasis – a potential target for a vaccine for the killer disease.
Case Western Reserve University

Contact: Kevin Mayhood
kevin.mayhood@case.edu
216-368-4442
Case Western Reserve University

Public Release: 4-Jan-2012
Neurology
Guidelines stress caution when combining anti-epileptic, HIV drugs
New guidelines from the American Academy of Neurology will help physicians better choose seizure drugs for people on HIV/AIDS medication, avoiding deadly drug interactions and preventing critical anti-HIV drugs from becoming less effective, possibly leading to a more virulent strain of the disease.
American Academy of Neurology

Contact: Jason Cody
codyja@msu.edu
517-432-0924
Michigan State University

Public Release: 3-Jan-2012
Journal of Virology
BUSM researchers identify novel compound to halt virus replication
BUSM researchers identify novel compound to halt virus replication.
National Institutes of Health, Transformative Medical Technologies Initiative

Contact: Jenny Eriksen Leary
jenny.eriksen@bmc.org
617-638-6841
Boston University Medical Center

Public Release: 28-Dec-2011
Journal of Infectious Diseases
UT Southwestern research suggests new way to ensure effectiveness of TB treatment
A UT Southwestern Medical Center study using a sophisticated "glass mouse" research model has found that multidrug-resistant tuberculosis is more likely caused in patients by speedy drug metabolism rather than inconsistent doses, as is widely believed.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Deborah Wormser
deborah.wormser@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center

Public Release: 28-Dec-2011
PLOS ONE
Microbial communities on skin affect humans' attractiveness to mosquitoes
The microbes on your skin determine how attractive you are to mosquitoes, which may have important implications for malaria transmission and prevention, according to a study published Dec. 28 in the online journal PLoS ONE.

Contact: Yael Franco
yfranco@plos.org
415-568-3169
Public Library of Science

Public Release: 22-Dec-2011
University of Texas chemist receives major grant to improve detection of drug-resistant tuberculosis
Developing a simple, paper-based test for drug-resistant tuberculosis is the goal of a University of Texas at Austin chemist, whose project just received a $1.6 million point-of-care diagnostics grant through Grand Challenges in Global Health, an initiative created by the Bill & Melinda Gates Foundation.
Bill & Melinda Gates Foundation

Contact: Andy Ellington
andy.ellington@mail.utexas.edu
512-232-3424
University of Texas at Austin

Public Release: 21-Dec-2011
Diabetes Care
More reasons to keep this New Year's weight loss resolution uncovered by Ben-Gurion U researchers
Rudich explains that switching to healthier dieting extends benefits beyond the single outcome of weight loss. In fact, important improvements that likely signify decreased risk for cardiovascular disease occur even despite weight regain, as long as dieting continues.
Israeli Ministry of Health/Chief Scientist Office, Deutsche Forschungsgemeinschaft of the Clinical Research Group Atherobesity, Dr. Robert C. and Veronica Atkins Research Foundation, German-Israeli Science Foundation

Contact: Andy Lavin
andrewlavin@alavin.com
516-944-4486
American Associates, Ben-Gurion University of the Negev

Public Release: 21-Dec-2011
Dissertations and Features
Do our medicines boost pathogens?
Scientists of the Institute of Tropical Medicine discovered a parasite that not only had developed resistance against a common medicine, but at the same time had become better in withstanding the human immune system. With some exaggeration: Medical practice helped in developing a superbug. "To our knowledge it is the first time such a doubly armed organism appears in nature," says researcher Manu Vanaerschot.

Contact: Jean-Claude Dujardin
jcdujardin@itg.be
32-324-76358
Institute of Tropical Medicine Antwerp

Public Release: 21-Dec-2011
International Journal of Services, Economics and Management
Even limited telemedicine could improve developing health
A lack of infrastructure in developing countries, and particularly in rural areas, often ensures that healthcare provision is absent. Research published in the International Journal of Services, Economics and Management by a team at Howard University in Washington DC suggests a solution to this insidious problem involving the development of telemedicine.

Contact: Albert Ang
ejournal@inderscience.com
Inderscience Publishers

Public Release: 21-Dec-2011
Science Translational Medicine
Study details how dengue infection hits harder the second time around
One of the most vexing challenges in the battle against dengue virus, a potentially fatal mosquito-borne virus, is that getting infected once can put people at greater risk for a more severe infection down the road. A new study with UC Berkeley researchers details how the interaction between a person's immune response and a subsequent dengue infection could mean the difference between getting a mild fever and going into fatal circulatory failure.
NIH/National Institute of General Medical Sciences, NIH/National Institute of Allergy and Infectious Diseases, Pediatric Dengue Vaccine Initiative

Contact: Sarah Yang
scyang@berkeley.edu
510-643-7741
University of California - Berkeley

Public Release: 21-Dec-2011
Science Translational Medicine
Genetics and immunity interact in dengue disease severity
Why one person and not another succumbs to dengue disease has been suspected, but not known. An international team has nailed down an important piece of the puzzle. Working with data from two long-term clinical studies of children in Nicaragua, they have captured the complex connection between a person's immune status and the viral genetics of dengue, both of which evolve over time.
NIH/National Institute of General Medical Sciences, Pediatric Dengue Vaccine Initiative, Helen Hay Whitney Postdoctoral Fellowship, others

Contact: Nicole Davis
ndavis@broadinstitute.org
617-714-7152
Broad Institute of MIT and Harvard

Public Release: 20-Dec-2011
Nature Communications
New candidate vaccine neutralizes all tested strains of malaria parasite
A new candidate malaria vaccine with the potential to neutralize all strains of the most deadly species of malaria parasite has been developed by a team led by scientists at the University of Oxford. The results of this new vaccine independently confirm the utility of a key discovery reported last month from scientists at the Wellcome Trust Sanger Institute who had identified this target within the parasite as a potential 'Achilles' heel' that could hold significant promise for vaccine development.
Wellcome Trust, Medical Research Council

Contact: Craig Brierley
c.brierley@wellcome.ac.uk
44-207-611-7329
Wellcome Trust

Public Release: 20-Dec-2011
PLOS Medicine
Estimating global malaria incidence
Estimates of malaria incidence derived from routine surveillance data suggest that 225 million episodes of malaria occurred worldwide in 2009. This estimate is lower than other published figures, such as those from the Malaria Atlas Project, particularly for estimates of malaria incidence outside Africa. Richard Cibulskis and colleagues at the WHO in Geneva, Switzerland present a critique of different estimation methods of the worldwide incidence of malaria in this week's PLoS Medicine.

Contact: Clare Weaver
press@plos.org
44-122-344-2834
Public Library of Science

Public Release: 19-Dec-2011
Proceedings of the National Academy of Sciences
Brain function - A new way to measure the burden of aging across nations
Cognitive function may be a better indicator of the impact of aging on an economy than age-distribution, with chronological age imposing less of a social and economic burden if the population is "functionally" younger, according to a study published today in the Proceedings of the National Academy of Sciences.

Contact: Leane Regan
regan@iiasa.ac.at
43-664-443-0368
International Institute for Applied Systems Analysis

Public Release: 16-Dec-2011
Emory and US CDC partner to continue building global public health network with $6 million grant
Emory University's Global Health Institute has received a three-year, $6 million grant from the Bill & Melinda Gates Foundation to further develop a model for strengthening national public health institutes (NPHIs) globally. The grant will build upon a previous foundation grant to the International Association of National Public Health Institutes (IANPHI), which since 2006 has created or increased capacity at NPHIs in 10 low-resource countries.
Bill & Melinda Gates Foundation

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory University

Public Release: 16-Dec-2011
Historic 'Grand Challenge' launched: Create low-cost devices for rapid disease diagnosis
Grand Challenges Canada and the Bill and Melinda Gates Foundation have teamed up on an unprecedented global effort to discover and develop affordable, easy-to-use tools to help developing country health workers rapidly diagnose diseases in rural communities. The expected result: more timely and appropriate treatment of illnesses in poor countries, potentially saving countless lives.
Grand Challenges Canada, Bill and Melinda Gates Foundation

Contact: Terry Collins
tc@tca.tc
416-538-8712
Sandra Rotman Centre for Global Health

Public Release: 15-Dec-2011
3-year study identifies key interventions to reduce maternal, newborn and child deaths
Some 56 evidence-based interventions will sharply reduce the 358,000 women who still die each year during pregnancy and childbirth and the 7.6 million children who die before the age of 5, according to a massive three-year global study.

Contact: Marshall Hoffman
marshall@hoffmanpr.com
703-533-3535
Partnership for Maternal, Newborn & Child Health

Public Release: 15-Dec-2011
BMC Biotechnology
Bacterial protein 'mops up' viruses found in contaminated water supplies
Access to clean water is a necessity often taken for granted. However UNICEF estimates that 900 million people across the world do not have access to safe drinking water. New research published in BioMed Central's open-access journal BMC Biotechnology shows that an enteric virus-binding protein, isolated from bacteria found in activated sludge, is able to capture viruses often present in contaminated water.

Contact: Dr. Hilary Glover
hilary.glover@biomedcentral.com
44-203-192-2370
BioMed Central

Showing releases 451-475 out of 496.

<< < 14 | 15 | 16 | 17 | 18 | 19 | 20 > >>